Allen Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Allen Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,095	Closed	-$586K	–	217
2023 Q3	$586K	Buy	10,095 +95	+1%	+$5.82K	0.01%	157
2023 Q2	$640K	Sell	10,000 -108	-1%	-$7.24K	0.01%	149
2023 Q1	$701K	Hold	10,108	–	–	0.01%	144
2022 Q4	$727K	Hold	10,108	–	–	0.01%	136
2022 Q3	$719K	Hold	10,108	–	–	0.01%	136
2022 Q2	$778K	Hold	10,108	–	–	0.01%	139
2022 Q1	$738K	Hold	10,108	–	–	0.01%	154
2021 Q4	$630K	Buy	+10,108	New	+$593K	0.01%	168

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Allen Investment Management's BMY Position: Q4 2023 in Review

Allen Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 10,095 shares — an estimated $586K sold.

Allen Investment Management first reported a position in BMY in Q4 2021 and held it in 8 quarters. The position peaked at $778K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Allen Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Allen Investment Management sold 10,095 Bristol-Myers Squibb shares in Q4 2023, an estimated $586K.
Allen Investment Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 8 quarters.
Allen Investment Management's Bristol-Myers Squibb position peaked at $778K in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Allen Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.